Departments of Medicine and Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
J Virol. 2012 Jan;86(2):898-908. doi: 10.1128/JVI.06415-11. Epub 2011 Nov 16.
Natural host sooty mangabeys (SM) infected with simian immunodeficiency virus SIVsmm do not develop AIDS despite high viremia. SM and other natural hosts express very low levels of CCR5 on CD4(+) T cells, and we recently showed that SIVsmm infection and robust replication occur in vivo in SM genetically lacking CCR5, indicating the use of additional entry pathways. SIVsmm uses several alternative coreceptors of human origin in vitro, but which molecules of SM origin support entry is unknown. We cloned a panel of putative coreceptors from SM and tested their ability to mediate infection, in conjunction with smCD4, by pseudotypes carrying Envs from multiple SIVsmm subtypes. smCXCR6 supported efficient infection by all SIVsmm isolates with entry levels comparable to those for smCCR5, and smGPR15 enabled entry by all isolates at modest levels. smGPR1 and smAPJ supported low and variable entry, whereas smCCR2b, smCCR3, smCCR4, smCCR8, and smCXCR4 were not used by most isolates. In contrast, SIVsmm from rare infected SM with profound CD4(+) T cell loss, previously reported to have expanded use of human coreceptors, including CXCR4, used smCXCR4, smCXCR6, and smCCR5 efficiently and also exhibited robust entry through smCCR3, smCCR8, smGPR1, smGPR15, and smAPJ. Entry was similar with both known alleles of smCD4. These alternative coreceptors, particularly smCXCR6 and smGPR15, may support virus replication in SM that have restricted CCR5 expression as well as SM genetically lacking CCR5. Defining expression of these molecules on SM CD4(+) subsets may delineate distinct natural host target cell populations capable of supporting SIVsmm replication without CD4(+) T cell loss.
天然宿主黑长尾猴(SM)感染猴免疫缺陷病毒 SIVsmm 后尽管病毒血症很高,但不会发展为艾滋病。SM 和其他天然宿主的 CD4(+)T 细胞上表达极低水平的 CCR5,我们最近表明,SM 中缺乏 CCR5 的遗传缺失会导致 SIVsmm 感染和体内的大量复制,表明存在其他进入途径。SIVsmm 在体外使用几种人类来源的替代核心受体,但 SM 来源的哪些分子支持进入尚不清楚。我们从 SM 中克隆了一组假定的核心受体,并结合携带来自多种 SIVsmm 亚型的 Envs 的假型物测试了它们介导感染的能力。smCXCR6 支持所有 SIVsmm 分离株的有效感染,其进入水平与 smCCR5 相当,smGPR15 使所有分离株以适度水平进入。smGPR1 和 smAPJ 支持低水平和可变的进入,而 smCCR2b、smCCR3、smCCR4、smCCR8 和 smCXCR4 则不被大多数分离株使用。相反,来自罕见的受感染 SM 的 SIVsmm 先前报道过广泛使用人类核心受体,包括 CXCR4,对 smCXCR4、smCXCR6 和 smCCR5 的利用效率很高,并且通过 smCCR3、smCCR8、smGPR1、smGPR15 和 smAPJ 也表现出强大的进入能力。使用两种已知的 smCD4 等位基因时,进入情况相似。这些替代核心受体,特别是 smCXCR6 和 smGPR15,可能支持在限制 CCR5 表达的 SM 以及遗传缺失 CCR5 的 SM 中病毒复制。确定这些分子在 SM CD4(+)亚群上的表达情况可能会阐明能够在不损失 CD4(+)T 细胞的情况下支持 SIVsmm 复制的不同天然宿主靶细胞群体。